Annual report pursuant to Section 13 and 15(d)

13. Business Combinations (Detail-Acquisitions)

v3.4.0.3
13. Business Combinations (Detail-Acquisitions) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Nov. 02, 2015
Aug. 26, 2014
May. 23, 2014
Mar. 18, 2014
Goodwill $ 0 $ 3,139,942        
Consideration given:            
Cash at closing 0 1,600,000        
Stock issued for acquisition, value   2,050,000        
CollabRx [Member]            
Cash     $ 4,737,773      
Accounts receivable     54,675      
Other current assets     105,700      
Property and equipment     92,636      
Accounts payable and accrued expenses     (1,620,000)      
Deferred revenue     (123,000)      
Other liabilities     (520,070)      
Derivative liabilties     (1,578,976)      
Identifiable intangible assets     170,000      
Total identifiable net assets     1,818,738      
Goodwill     $ 12,237,380      
Total consideration 13,510,777          
Epinex Diagnostics Laboratories, Inc. [Member]            
Cash       $ 36,677    
Property and equipment       26,983    
Deposits       285    
Accounts payable and accrued expenses       (227,855)    
Accrued expenses       (75,945)    
Identifiable intangible assets       900,000    
Total identifiable net assets       660,145    
Goodwill 0 581,600   $ 581,600    
Total consideration   1,241,745        
Consideration given:            
Cash at closing   100,000        
Acquisition notes   $ 385,545        
Stock issued for acquisition, shares   100,000        
Stock issued for acquisition, value   $ 800,000        
Contingent consideration adjustment   (43,800)        
GlobalOne Information Technologies, LLC [Member]            
Accounts receivable         $ 93,270  
Property and equipment         7,005  
Software         182,000  
Accounts payable and accrued expenses         (95,086)  
Identifiable intangible assets         213,000  
Total identifiable net assets         400,189  
Goodwill         $ 274,811  
Total consideration   675,000        
Consideration given:            
Cash at closing   $ 500,000        
Stock issued for acquisition, shares   10,000        
Stock issued for acquisition, value   $ 25,000        
Contingent consideration adjustment   150,000        
Clinlab, Inc. [Member]            
Cash           $ 31,671
Accounts receivable           54,017
Other current assets           241
Software           1,252,000
Deposits           700
Accounts payable and accrued expenses           (4,942)
Accrued expenses           (39,202)
Identifiable intangible assets           152,000
Total identifiable net assets           1,446,485
Goodwill $ 0 857,532       $ 857,532
Total consideration   2,304,017        
Consideration given:            
Cash at closing   $ 1,000,000        
Stock issued for acquisition, shares   200,000        
Stock issued for acquisition, value   $ 1,250,000        
Contingent consideration adjustment   $ 54,017